The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Eugia Pharma Specialities restarts production at terminally sterilized product lines
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
The company will address the observations within a stipulated timeline working with the regulators
_256_384.jpg)
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
The plant will have installed production capacity of 3,120 MT/month
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Subscribe To Our Newsletter & Stay Updated
